Rapid Micro Biosystems (RPID) Cash & Current Investments (2020 - 2026)

Rapid Micro Biosystems' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $22.9 million for Q1 2026.

• In Q1 2026, Cash & Current Investments changed 0.37% year-over-year to $22.9 million; the TTM figure through Mar 2026 stood at $22.9 million (changed 0.37% YoY), while the FY2025 annual figure was $18.4 million, down 46.02% from the prior year.
• Cash & Current Investments came in at $22.9 million for Q1 2026 at Rapid Micro Biosystems, up from $18.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $162.2 million in Q1 2022 to a low of $18.4 million in Q4 2025.
• A 5-year average of $63.0 million and a median of $50.7 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 109.1% in 2023 and plunged 71.25% in 2025, its largest moves.
• Rapid Micro Biosystems' Cash & Current Investments stood at $81.8 million in 2022, then rose by 12.56% to $92.1 million in 2023, then slumped by 63.04% to $34.0 million in 2024, then plunged by 46.02% to $18.4 million in 2025, then grew by 24.95% to $22.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $22.9 million, $18.4 million, and $41.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison